Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Gaucher Disease

被引:11
作者
Machaczka, Maciej [1 ,2 ]
机构
[1] Karolinska Univ Hosp Huddinge, Hematol Ctr Karolinska, SE-14186 Stockholm, Sweden
[2] Karolinska Inst, Div Hematol, Dept Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden
关键词
allogeneic; Gaucher disease; hematopoietic stem cell transplantation; outcome; BONE-MARROW TRANSPLANTATION; GLUCOCEREBROSIDASE GENE; NORRBOTTNIAN TYPE; EXPERIENCE; MUTATION;
D O I
10.3109/08880018.2013.793757
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ito and Barrett recently reviewed the international experiences with allogeneic hematopoietic stem cell transplantation (allo-HSCT) for the treatment of the neuronopathic and non-neuronopathic forms of Gaucher disease (GD). In the present communication, the author adds some updated data on the long-term outcome of allo-HSCT for Swedish GD patients with the mean and median follow-up time of 27 years (the longest follow-up of 30 years) and makes comments on some of the authors' statements found in the article.
引用
收藏
页码:459 / 461
页数:3
相关论文
共 10 条
[1]  
DAHL N, 1990, AM J HUM GENET, V47, P275
[2]   GAUCHER DISEASE - NORRBOTTNIAN TYPE .1. GENERAL CLINICAL DESCRIPTION [J].
DREBORG, S ;
ERIKSON, A ;
HAGBERG, B .
EUROPEAN JOURNAL OF PEDIATRICS, 1980, 133 (02) :107-118
[3]  
HOBBS JR, 1987, LANCET, V1, P1111
[4]   Gaucher disease:: Mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA) [J].
Hruska, Kathleen S. ;
LaMarca, Mary E. ;
Scott, C. Ronald ;
Sidransky, Ellen .
HUMAN MUTATION, 2008, 29 (05) :567-583
[5]   Gauchers Disease-A Reappraisal of Hematopoietic Stem Cell Transplantation [J].
Ito, Sawa ;
Barrett, A. John .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2013, 30 (02) :61-70
[6]   Substrate reduction therapy with miglustat for type 1 Gaucher disease: A retrospective analysis from a single institution [J].
Machaczka, Maciej ;
Hast, Robert ;
Dahlman, Ingrid ;
Lerner, Richard ;
Klimkowska, Monika ;
Engvall, Martin ;
Hagglund, Hans .
UPSALA JOURNAL OF MEDICAL SCIENCES, 2012, 117 (01) :28-34
[7]   LONG-TERM FOLLOW-UP OF THE 1ST SUCCESSFUL BONE-MARROW TRANSPLANTATION IN GAUCHER DISEASE [J].
RINGDEN, O ;
GROTH, CG ;
ERIKSON, A ;
BACKMAN, L ;
GRANQVIST, S ;
MANSSON, JE ;
SVENNERHOLM, L .
TRANSPLANTATION, 1988, 46 (01) :66-70
[8]   Allogeneic hematopoietic stem cell transplantation for inherited disorders:: Experience in a single center [J].
Ringdén, O ;
Remberger, M ;
Svahn, BM ;
Barkholt, L ;
Mattsson, J ;
Aschan, J ;
Le Blanc, K ;
Gustafsson, B ;
Hassan, Z ;
Omazic, B ;
Svenberg, P ;
Solders, G ;
von Döbeln, U ;
Winiarski, J ;
Ljungman, P ;
Malm, G .
TRANSPLANTATION, 2006, 81 (05) :718-725
[9]   10 YEARS EXPERIENCE OF BONE-MARROW TRANSPLANTATION FOR GAUCHER DISEASE [J].
RINGDEN, O ;
GROTH, CG ;
ERIKSON, A ;
GRANQVIST, S ;
MANSSON, JE ;
SPARRELID, E .
TRANSPLANTATION, 1995, 59 (06) :864-870
[10]   How I treat Gaucher disease [J].
Zimran, Ari .
BLOOD, 2011, 118 (06) :1463-1471